Clinical Trials Browser

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT05001724 2023-04-25

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

Phase 2/3 Terminated

16 enrolled

Thoracic

Advanced Non-small Cell Lung Cancer

NCT01907009 2023-04-19

MEL-CAP

Phase 2/3 Terminated

29 enrolled

Genitourinary

Castrate Resistant Prostate Cancer

NCT03354611 2023-03-16

Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging

Phase 2/3 Terminated

21 enrolled

Breast

Breast Neoplasms

NCT04969861 2023-01-12

BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)

Phase 2/3 Terminated

1 enrolled 6 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00096460 2023-01-05

BMT CTN 0202

Phase 2/3 Terminated

30 enrolled 5 charts

Lymphoid

Lymphoma, Follicular

NCT03870152 2022-10-31

EARL

Phase 2/3 Terminated

13 enrolled

Thoracic

Lung Cancer Squamous Cell

NCT00247975 2022-08-16

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Phase 2/3 Terminated

36 enrolled

Breast

Breast Neoplasms, Heart Failure

NCT03674242 2022-08-01

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)

Phase 2/3 Terminated

27 enrolled

Breast

Triple Negative Breast Neoplasms

NCT02793583 2022-07-21

UNITY-NHL

Phase 2/3 Terminated

710 enrolled 1 FDA

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT02614703 2021-08-27

"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

Phase 2/3 Terminated

60 enrolled 6 charts

Gastrointestinal

Barrett Esophagus

NCT02354144 2021-06-15

LIMIT-HPV

Phase 2/3 Terminated

258 enrolled 11 charts

Papillomavirus Infections

NCT00967343 2021-06-14

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Phase 2/3 Terminated

40 enrolled 10 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Myeloid, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01437514 2021-06-07

Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer

Phase 2/3 Terminated

410 enrolled

Gastrointestinal

Neoplasm Metastasis, Rectal Neoplasms

NCT03158610 2021-05-03

Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer

Phase 2/3 Terminated

20 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01438112 2021-04-14

BOND

Phase 2/3 Terminated

22 enrolled

Genitourinary

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

NCT00448266 2021-01-22

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Phase 2/3 Terminated

12 enrolled

Breast

Breast Neoplasms

NCT01774578 2020-05-28

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Phase 2/3 Terminated

135 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT03716050 2020-05-21

The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems

Phase 2/3 Terminated

17 enrolled 10 charts

Breast

Breast Neoplasms

NCT02256124 2020-04-14

NF1-EXCEL

Phase 2/3 Terminated

41 enrolled

CNS

Neurofibromatosis 1

NCT02926638 2020-03-19

Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Phase 2/3 Terminated

9 enrolled 5 charts

MET Positive

NCT02414165 2020-02-07

Toca5

Phase 2/3 Terminated

403 enrolled

CNS

Astrocytoma, Glioblastoma, Recurrence

Clinical Trials

SPARK-ALL: Calaspargase Pegol in Adults With ALL

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

ORIGAMA

POPLAR-NF2

REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma

Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer

BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer

CAN-STAMP

SUNRISELMS

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC

SIRCCA

TYPP

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

DETECTION

NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

Prevent

ULTRA-V

Esostrate

Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH

THRIVE

VOICE

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

MEL-CAP

Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging

BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)

BMT CTN 0202

EARL

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)

UNITY-NHL

"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

LIMIT-HPV

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer

Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer

BOND

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems

NF1-EXCEL

Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Toca5